Synageva BioPharma Announces Support of Annual Rare Disease Day - Initiates First Ever Clinical Program for Lysosomal Acid Lipase Deficiency

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp., a privately held biopharmaceutical company that is developing therapeutic products for rare disorders, announced today that the company is supporting the Fourth International Rare Disease Day observance on February 28, 2011.